Analysts expect that Aetna Inc (NYSE:AET) will announce earnings of $3.03 per share for the current quarter, according to Zacks. Six analysts have provided estimates for Aetna’s earnings. The highest EPS estimate is $3.20 and the lowest is $2.82. Aetna posted earnings per share of $2.71 during the same quarter last year, which would indicate a positive year over year growth rate of 11.8%. The firm is scheduled to report its next earnings results on Tuesday, May 1st.
According to Zacks, analysts expect that Aetna will report full-year earnings of $11.01 per share for the current financial year, with EPS estimates ranging from $9.90 to $11.53. For the next fiscal year, analysts expect that the business will post earnings of $12.17 per share, with EPS estimates ranging from $11.00 to $13.15. Zacks’ EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Aetna.
Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.07. The company had revenue of $14.74 billion for the quarter, compared to the consensus estimate of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. Aetna’s revenue for the quarter was down 6.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.08 earnings per share.
A number of brokerages have issued reports on AET. Piper Jaffray Companies upgraded Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target on the stock in a research report on Wednesday, January 3rd. Wells Fargo & Co reiterated an “outperform” rating and set a $208.00 price target (up previously from $200.00) on shares of Aetna in a research report on Monday, December 4th. Morgan Stanley downgraded Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price target on the stock. in a research report on Wednesday, December 20th. Deutsche Bank upgraded Aetna from a “hold” rating to a “buy” rating and increased their price target for the stock from $195.00 to $212.00 in a research report on Monday, January 22nd. Finally, ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Ten investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $185.94.
Several institutional investors have recently made changes to their positions in AET. Farallon Capital Management LLC acquired a new stake in shares of Aetna in the fourth quarter valued at approximately $940,734,000. Deutsche Bank AG increased its holdings in shares of Aetna by 57.5% in the fourth quarter. Deutsche Bank AG now owns 2,704,723 shares of the company’s stock valued at $487,900,000 after purchasing an additional 987,156 shares during the last quarter. Alpine Associates Management Inc. acquired a new stake in shares of Aetna in the fourth quarter valued at approximately $159,933,000. Amundi Pioneer Asset Management Inc. increased its holdings in shares of Aetna by 1,087.9% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 926,948 shares of the company’s stock valued at $167,213,000 after purchasing an additional 848,913 shares during the last quarter. Finally, Hudson Bay Capital Management LP increased its holdings in shares of Aetna by 462.4% in the fourth quarter. Hudson Bay Capital Management LP now owns 845,810 shares of the company’s stock valued at $152,576,000 after purchasing an additional 695,428 shares during the last quarter. 84.88% of the stock is owned by institutional investors and hedge funds.
Shares of Aetna (AET) traded up $1.34 during mid-day trading on Monday, reaching $178.51. The company’s stock had a trading volume of 2,138,300 shares, compared to its average volume of 2,896,321. The stock has a market capitalization of $58,360.00, a P/E ratio of 29.51, a P/E/G ratio of 1.45 and a beta of 0.60. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52. Aetna has a 52 week low of $124.83 and a 52 week high of $194.40.
The company also recently announced a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Thursday, January 11th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. Aetna’s payout ratio is currently 33.06%.
TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Expect Aetna Inc (AET) Will Announce Earnings of $3.03 Per Share” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/19/zacks-brokerages-expect-aetna-inc-aet-will-announce-earnings-of-3-03-per-share.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Get a free copy of the Zacks research report on Aetna (AET)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.